Press release
Head and Neck Cancer (HNC) Market to Grow at a Significant Growth Rate During the Study Period (2019-32) - Estimates DelveInsight | Innate Pharma, Coherus, Kura Oncology, GlaxoSmithKline, Debiopharm, MacroGenics, Roche, Merck, Junshi Biosciences,
DelveInsight's "Head and Neck Cancer Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Head and Neck Cancer Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).
The market report covers emerging drugs, treatment practices, market share of individual Head and Neck Cancer therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Head and Neck Cancer treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.
Head and Neck Cancer: An Overview
Head and Neck Cancer (HNC) usually begins in the squamous cells - often referred to as squamous cell carcinomas of the head and neck - that line the mucosal surfaces of the head and neck (for example, those inside the mouth, throat, and voice box. They can also begin in the salivary glands, sinuses, muscles, or nerves, but they are less common than squamous cell carcinomas. HNC begins in several places in the head and throat, excluding brain or eye cancer.
The types of HNC include laryngeal cancer, nasopharyngeal cancer, hypopharyngeal cancer, nasal cavity and paranasal sinus cancer, salivary gland cancer, oral cancer, oropharyngeal cancer, and tonsil cancer. Histologically, progression to invasive HNSCC follows an ordered series beginning with epithelial cell hyperplasia, followed by dysplasia (mild, moderate, and severe), carcinoma in situ, and, ultimately, invasive carcinoma.
There are many tests used for diagnosing HNC- physical examination/blood and urine tests, endoscopy, biopsy, biomarker testing of the tumor, X-ray/barium swallow, panoramic radiograph, ultrasound, magnetic resonance imaging, bone scan, etc.
Head and Neck Cancer Market Key Facts
• In 2021, the Head and Neck Cancer market size in the US was USD 1,831 million.
• Among the EU-5 countries, Germany had the highest Head and Neck Cancer market size in 2021, i.e., USD 219 million. The lowest Head and Neck Cancer market size was estimated in Italy with USD 114 million in 2021.
• In Japan, the Head and Neck Cancer market size was observed to be of USD 187 million in 2021.
• The Head and Neck Cancer market size in The United States will grow at a CAGR of 8.2% by 2032.
• In 2021, the total Head and Neck Cancer incident cases in the 7MM countries were ~158,000, and these cases are anticipated to increase during the study period.
• Among the European countries, Germany had the highest number of incident cases of Head and Neck Cancer in 2021, i.e., ~20,000 cases, followed by France which had ~16,000 incident cases in 2021. On the other hand, Italy had the lowest number of incident cases of Head and Neck Cancer, i.e. ~9900 cases in 2021. Japan had ~20,000 incident cases of HNC in 2021.
Head and Neck Cancer Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Head and Neck Cancer therapies in the market. It also provides a detailed assessment of the Head and Neck Cancer market drivers & barriers, unmet needs, and emerging technologies.
The report gives complete detail of the market trend for each marketed Head and Neck Cancer drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MOA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Discover How Head and Neck Cancer Market will Grow by 2032:
https://www.delveinsight.com/report-store/head-and-neck-cancer-hnc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Head and Neck Cancer Epidemiology
The epidemiology section covers detailed insights into the historical, and current Head and Neck Cancer patient pool and forecasted epidemiology trends for every seven major countries (7MM) from 2019 to 2032.
The Reports Cover the Head and Neck Cancer Epidemiology Segmented as -
• HPV-specific Incident Cases of Head and Neck Cancer (HNC) in the 7MM [2019-2032]
• Site-specific Incident Cases of Head and Neck Cancer (HNC) in the 7MM [2019-2032]
• Total Incident Cases of Head and Neck Cancer (HNC) in the 7MM [2019-2032]
• Stage-specific Incident Cases of Head and Neck Cancer (HNC) in the 7MM [2019-2032]
• Molecular Alteration-specific Incident Cases of Head and Neck Cancer (HNC) in the 7MM [2019-2032]
Get Key Insights Into the Evolving Head and Neck Cancer Epidemiology Trends:
https://www.delveinsight.com/report-store/head-and-neck-cancer-hnc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Head and Neck Cancer Drugs Uptake and Pipeline Development Activities
The drugs' uptake section focuses on the rate of uptake of the potential drugs recently launched in the Head and Neck Cancer market or expected to be launched during the study period. The analysis covers the market share by Head and Neck Cancer drugs, patient uptake by therapies, and sales of each drug.
The report's drugs uptake section helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It allows the comparison of the drugs based on market share and size, which again will be helpful in investigating factors important in understanding the market dynamics and in making financial and regulatory decisions.
The report also covers the Head and Neck Cancer Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Explore More About Ongoing Pipeline Development Activities:
https://www.delveinsight.com/sample-request/head-and-neck-cancer-hnc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Head and Neck Cancer Therapeutics Assessment
Several major pharma and biotech companies are developing therapies for Head and Neck cancer. Currently, Innate Pharma is leading the therapeutics market with its Head and Neck cancer drug candidates in the most advanced stage of clinical development.
Head and Neck Cancer Companies Active in the Therapeutics Market Include
CEL-SCI, Junshi Biosciences, Coherus, Exelixis, Immutep S.A.S., Merck Sharp & Dohme LLC, Iovance Biotherapeutics, BeiGene, Akeso, Chia Tai-Tianqing, Kura Oncology, Hoffmann-La Roche, Eli Lilly and Company, and many others.
Emerging and Marketed Head and Neck Cancer Therapies Covered in the Report Include
• Enoblituzumab: MacroGenics
• KEYTRUDA (pembrolizumab): Merck Sharp & Dohme
• Monalizumab: Innate Pharma
• Niraparib: GlaxoSmithKline
• TECENTRIQ (Atezolizumab): Hoffmann-La Roche
• Tipifarnib: Kura Oncology
• Toripalimab: Junshi Biosciences/Coherus
• XEVINAPANT (debio 1143): Merck KGaA
• Xevinapant: Debiopharm
And Many More
Learn More About the Emerging Therapies & Key Companies in the Head and Neck Cancer Therapeutics Market:
https://www.delveinsight.com/sample-request/head-and-neck-cancer-hnc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Head and Neck Cancer Competitive Intelligence Analysis
4. Head and Neck Cancer Market Overview at a Glance
5. Head and Neck Cancer Background and Overview
6. Head and Neck Cancer Patient Journey
7. Head and Neck Cancer Epidemiology and Patient Population
8. Head and Neck Cancer Treatment Algorithm, Current Treatment, and Medical Practices
9. Head and Neck Cancer Unmet Needs
10. Key Endpoints of Head and Neck Cancer Treatment
11. Head and Neck Cancer Marketed Products
12. Head and Neck Cancer Emerging Therapies
13. Head and Neck Cancer Seven Major Market Analysis
14. Attribute Analysis
15. Head and Neck Cancer Market Outlook (7 major markets)
16. Head and Neck Cancer Access and Reimbursement Overview
17. KOL Views on the Head and Neck Cancer Market.
18. Head and Neck Cancer Market Drivers
19. Head and Neck Cancer Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Download the Sample PDF to Get Detailed Insights About the Report's Offerings:
https://www.delveinsight.com/sample-request/head-and-neck-cancer-hnc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight -
• Bowen's Disease Market
https://www.delveinsight.com/report-store/bowens-disease-market
• Cartilage Diseases Market
https://www.delveinsight.com/report-store/cartilage-diseases-market
• Charcot-Marie-Tooth Disease Market
https://www.delveinsight.com/report-store/charcot-marie-tooth-disease-market
• Cryptococcosis Market
https://www.delveinsight.com/report-store/cryptococcosis-market
• Dental Lasers Market
https://www.delveinsight.com/report-store/dental-lasers-market
• Diabetes Market
https://www.delveinsight.com/report-store/diabetes-market
• Diverticulitis Market
https://www.delveinsight.com/report-store/diverticulitis-market
• Down Syndrome Market
https://www.delveinsight.com/report-store/down-syndrome-market
• Endocarditis Market
https://www.delveinsight.com/report-store/endocarditis-market
• Extracorporeal Circulation System Market
https://www.delveinsight.com/report-store/extracorporeal-circulation-system-market
• Gastro Intestinal Bleeding Market
https://www.delveinsight.com/report-store/gastro-intestinal-bleeding-market
• Gene Therapy for Ocular Rare Disease Market
https://www.delveinsight.com/report-store/gene-therapy-for-ocular-rare-disease-market
• Germ Cell Tumor Market
https://www.delveinsight.com/report-store/germ-cell-tumor-market
• India Healthcare Outlook
https://www.delveinsight.com/report-store/india-healthcare-outlook-report
• Insulin Glargine Biosimilar Insight
https://www.delveinsight.com/report-store/insulin-glargine-biosimilar-insight
• Listeriosis Market
https://www.delveinsight.com/report-store/listeriosis-market
• Liver Angiosarcoma Market
https://www.delveinsight.com/report-store/liver-angiosarcoma-market
Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Head and Neck Cancer (HNC) Market to Grow at a Significant Growth Rate During the Study Period (2019-32) - Estimates DelveInsight | Innate Pharma, Coherus, Kura Oncology, GlaxoSmithKline, Debiopharm, MacroGenics, Roche, Merck, Junshi Biosciences, here
News-ID: 3129522 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Head
Green Dot Sign® Going Head-to-Head with Traditional Plastic ADA Signs
After the success of their groundbreaking sustainable ADA compliant interior signs, Green Dot Sign® is now offering a more affordable and adaptable option than ever before: Low profile office signs.
Nussbaum started considering environmentally-friendly manufacturing methods and products while working at his prior sign company. The idea to create signage from a wood base and non-toxic 3D printed material for lettering, braille, and pictograms was sparked by a braille sign with…
China and India are growing head to head in Companion Diagnostic market
“Asia-Pacific Companion Diagnostics Market" research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 27.91% to reach USD 2.17 billion by 2021, from USD 0.63 billion in 2016, which amounts to a cumulative growth of USD 1.54 billion.
A companion diagnostics device is a medical device that provides information which is necessary for drug safety and effectives or any other biological product. This helps…
East and West going head to head in Asia-Pacific Food Emulsifiers Market
Asia-Pacific Food Emulsifiers Market" research report, published by Market Data Forecast delineates that the market is growing with a CAGR of 6.15% to reach USD 0.78 billion by 2021, from USD 0.58 billion in 2016, which amounts to a cumulative growth of USD 0.20 billion.
View Full Report at http://www.marketdataforecast.com/market-reports/asia-pacific-food-emulsifiers-market-564/
Download Free Sample report at http://www.marketdataforecast.com/market-reports/asia-pacific-food-emulsifiers-market-564/request-sample
A substance used in food manufacturing which helps to combine liquids of different thicknesses is known as…
dinCloud Earns Top Marks in Head-to-Head Comparison
The #1 Brand in Hosted Virtual Desktops
LOS ANGELES, CA – June 19, 2012 – dinCloud, a cloud transformation company and provider of hosted virtual desktops, has come out on top as the leading provider of DaaS (Desktop as a Service) in a head-to-head comparison of five market leaders by ExtremeLabs. dinCloud’s solution received the groupings highest marks for the solution’s good control, as well as fast response, and was the…
University Students go head to head in University of Bolton’s “Sports Fiesta …
The University of Bolton Student’s Council and the Student Activities Department organized an integrated program of sporting activities around the theme "Sports Fiesta 2012" which drew a number of Universities from the Northern Emirates and Dubai.
The activities took place at UOB RAK Campus. Separate activities for male and female attendees included; badminton, basketball, chess, cricket, darts, tug-o-war, sprint race, football and volleyball matches, and other recreational games.
To coincide with the…
KnowledgetoAction Departments Go Head to Head in a Bowling Competition
London, UK ( ) October 25, 2010 - Employees of KnowledgetoAction (http://knowledgeandaction.co.uk) have been going head to head against each other in a series of team building competitions that began on September 1, 2010. Knowledge to Action believes strongly in team building and this event showcased their desire for excellent team cooperation and communication between departments, allowing for more cohesiveness within Knowledge to Action.
Most recently, each of the KnowledgetoAction…
